KE News & Events

Reports Q3 revenue $352.9M, consensus $356.27M. Commenting on today's announcement, Richard D. Phillips, Chief Executive Officer, stated, "Results for the third quarter were in line with expectations. Sales increased sequentially compared to Q2, driven by strong growth in our medical vertical market, margins remained solid, and cash from operations was positive for the ninth consecutive quarter. We expect Q4 to be a good finish to the year and we are affirming our guidance for fiscal 2026 with adjusted operating margin estimated to be at the high end of the range."

Backs FY26 CapEx view $50M-$60M.

Consensus $1.4B. Adjusted operating income is estimated to be 4.2% - 4.5% of net sales versus the prior estimate of 4.0% - 4.25% The guidance for capital expenditures did not change with a range of $50 - $60 million.

Reports Q2 revenue $341.3M, consensus $339.34M. Commenting on today's announcement, Richard D. Phillips, Chief Executive Officer, stated, "I'm pleased with the results for the second quarter and our updated guidance for fiscal 2026. Sales in Q2 were in line with expectations, highlighted by another quarter of strong double-digit year-over-year growth in the medical vertical, margins improved compared to the same period last year, and cash from operations was positive for the eighth consecutive quarter."